 |
인쇄하기
취소
|
UCB Korea holds Vimpat symposium
Scores of neurologists and pediatricians at home and abroad gathered in Seoul and Busan between January 13 and 14 to participate in a launching symposium of Vimpat (lacosamide) on the future strategy of epilepsy.
The theme of the two-day symposium, organized by UCB Korea, is “Insight into Epilepsy and Treatment.”
In Korea, Vimpat was approved in 2010 as adjunctive therapy for the treatmen...
The theme of the two-day symposium, organized by UCB Korea, is “Insight into Epilepsy and Treatment.”
In Korea, Vimpat was approved in 2010 as adjunctive therapy for the treatmen...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.